VSee Health (VSEE) Competitors $0.84 +0.01 (+0.98%) Closing price 03:52 PM EasternExtended Trading$0.84 +0.00 (+0.23%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSEE vs. BGLC, SSY, MGRX, ACON, ATIP, DHAC, NIVF, OTRK, BACK, and BTTXShould you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Mangoceuticals (MGRX), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), Ontrak (OTRK), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. VSee Health vs. Its Competitors BioNexus Gene Lab SunLink Health Systems Mangoceuticals Aclarion ATI Physical Therapy Digital Health Acquisition NewGenIvf Group Ontrak IMAC Better Therapeutics BioNexus Gene Lab (NASDAQ:BGLC) and VSee Health (NASDAQ:VSEE) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings. Do analysts rate BGLC or VSEE? VSee Health has a consensus price target of $5.00, indicating a potential upside of 496.59%. Given VSee Health's stronger consensus rating and higher probable upside, analysts clearly believe VSee Health is more favorable than BioNexus Gene Lab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00VSee Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has preferable valuation & earnings, BGLC or VSEE? BioNexus Gene Lab has higher revenue and earnings than VSee Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.55M1.05-$1.60MN/AN/AVSee Health$6.38M0.47-$4.41MN/AN/A Does the media refer more to BGLC or VSEE? In the previous week, VSee Health had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for VSee Health and 1 mentions for BioNexus Gene Lab. VSee Health's average media sentiment score of 0.01 beat BioNexus Gene Lab's score of -1.29 indicating that VSee Health is being referred to more favorably in the news media. Company Overall Sentiment BioNexus Gene Lab Negative VSee Health Neutral Is BGLC or VSEE more profitable? VSee Health has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. VSee Health's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-30.70% -35.54% -29.08% VSee Health N/A N/A N/A Do insiders & institutionals have more ownership in BGLC or VSEE? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. Comparatively, 1.0% of VSee Health shares are owned by institutional investors. 0.7% of BioNexus Gene Lab shares are owned by insiders. Comparatively, 6.6% of VSee Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryVSee Health beats BioNexus Gene Lab on 9 of the 13 factors compared between the two stocks. Get VSee Health News Delivered to You Automatically Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSEE vs. The Competition Export to ExcelMetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$3.02M$19.34B$29.79B$9.76BDividend YieldN/A3.69%3.07%4.08%P/E RatioN/A74.2754.4326.03Price / Sales0.47191.571,896.74103.94Price / CashN/A83.8033.6428.79Price / Book-0.258.097.296.08Net Income-$4.41M$346.10M$806.27M$265.64M7 Day Performance8.70%2.31%2.31%3.11%1 Month Performance-36.98%-4.17%0.18%0.39%1 Year Performance-50.99%56.19%24,053.21%18.52% VSee Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSEEVSee Health1.514 of 5 stars$0.84+1.0%$5.00+496.6%-51.5%$3.02M$6.38M0.00N/AGap UpBGLCBioNexus Gene Lab0.027 of 5 stars$5.32flatN/A+33.5%$9.58M$9.51M0.0030Negative NewsSSYSunLink Health SystemsN/A$1.12+16.6%N/A+38.1%$7.88M$31.09M4.661,376Gap UpMGRXMangoceuticals0.5741 of 5 stars$1.51-3.5%N/A-97.3%$7.81M$620K-0.393ACONAclarion1.5107 of 5 stars$7.02-3.6%$11,758.50+167,400.0%-99.7%$4.07M$50K0.007Gap DownATIPATI Physical TherapyN/A$0.68flatN/A-88.6%$2.98M$741.86M-0.045,600DHACDigital Health AcquisitionN/A$0.81+3.6%N/A-52.0%$2.92MN/A0.002,021Gap UpNIVFNewGenIvf GroupN/A$1.83-4.2%N/A-99.8%$1.58M$5.43M0.00N/APositive NewsGap DownOTRKOntrak1.773 of 5 stars$0.10-68.8%$3.00+2,900.0%-97.1%$422K$10.85M-0.01250Negative NewsGap DownBACKIMACN/A$0.08-17.3%N/A-95.3%$168K$72.05K0.00180Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040 Related Companies and Tools Related Companies BioNexus Gene Lab Competitors SunLink Health Systems Competitors Mangoceuticals Competitors Aclarion Competitors ATI Physical Therapy Competitors Digital Health Acquisition Competitors NewGenIvf Group Competitors Ontrak Competitors IMAC Competitors Better Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSEE) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VSee Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VSee Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access